Division of Microbiological Studies, Food and
Drug Administration, Washington, DC 20204,1 and
Food and Drug Administration Pacific Regional Laboratory,
Northwest District, Bothell, Washington 980412
Received 29 June 2000/Returned for modification 25 September
2000/Accepted 16 October 2000
 |
INTRODUCTION |
Symptoms of food-borne infections
with enterohemorrhagic Escherichia coli (EHEC) can range
from mild diarrhea to bloody diarrhea or hemorrhagic colitis (HC),
which may progress to the life-threatening hemolytic-uremic
syndrome (HUS). EHEC strains are distinguished from the other
pathogenic E. coli groups by their unique virulence factors. These include the production of Shiga toxins (Stxs); the
presence of the locus for the enterocyte effacement island, which
carries the eaeA gene (which encodes the intimin protein essential for cellular attachment), and the presence of a 60-MDa plasmid (pO157) that carries the ehxA (EHEC hlyA)
gene that encodes EHEC hemolysin or enterohemolysin. Although Stx is
considered the primary virulence factor, in the more severe forms of
EHEC infections, it appears that combinations of these factors are required for full virulence (2, 19).
EHEC serotype O157:H7 strains account for most of the food-borne
outbreaks worldwide; however, non-O157:H7 serotypes are also implicated
in illness (17, 19). In the United States, food-borne outbreaks caused by non-O157:H7 strains are infrequent. However, this may in part be attributed to the fact that most detection methods
used are specific for the O157:H7 serotype. Still, few outbreaks caused
by non-O157:H7 strains have occurred, such as the 1994 outbreak
in Montana, in which serotype O104:H21 was implicated. In that
incident, there were 11 confirmed cases and 7 suspected cases of
infection, with 16 of the patients having hemorrhagic colitis. It was
speculated that none of the cases progressed to HUS because those
infected were 8 years of age or older and therefore were not as
susceptible as the younger populations (18). Consumption of contaminated pasteurized milk was suspected but not confirmed, as
O104:H21 was isolated only from the stool samples of infected patients
and not from the product (10). Characterization of the
O104:H21 isolates showed that all had identical patterns on pulsed-field gel electrophoresis, produced only Stx2, and did not
ferment sorbitol. The latter phenotype actually enabled their isolation, since sorbitol-containing medium was used in the analysis. Previously, an O104:H2 serotype that produced only Stx2 and that did
not have ehxA or eaeA genes was implicated in a
HUS infection in the United Kingdom (28). In Germany, an
O104:H
strain isolated from a patient with HUS was also
found to produced only Stx2, but the strain was not tested for other
virulence markers (6). Since Stx2 was also the only
virulence factor reported for the O104:H21 isolates from the Montana
outbreak, we examined these strains for the presence of other EHEC
virulence factors.
| |
MATERIALS AND METHODS |
Bacterial strains.
Isolates of the O104:H21 serotype,
strains G5506, G5507, and G5508, were obtained from the Centers for
Disease Control and Prevention, Atlanta, Ga. Strain 35150, an O157:H7
serotype strain that produces both Stx1 and Stx2, was obtained from the
American Type Culture Collection, Manassas, Va. Strain E2348/69, an
enteropathogenic E. coli (EPEC) strain of the O127:H6
serotype, was obtained from T. Whittam, Pennsylvania State University.
Other strains were from the culture collection at the Food and Drug
Administration and included 13C60, a patient isolate of the O26:H11
serotype that produces Stx1, and 13C09, an O48:H21 serotype strain that produces Stx2 that was isolated from a 1.5-year-old patient with bloody diarrhea.
Multiplex PCR analysis.
Isolates were analyzed by PCR for
the presence of virulence genes. The multiplex assay used was a
combination and modification of two PCR assays that allowed
amplification of five genes in a single reaction. Three primer pairs,
indicated in parentheses, were derived from the mismatch amplification
mutation assay that amplifies 348 bp from the stx1 allele
(primers LP30 and LP31), 584 bp from the stx2 allele
(primers LP43 and LP44), and 252 bp from the uidA (also
known as gusA) allele (primers PT-2 and PT-3) that is
specific for the O157:H7 serotype (9). These were combined with primers that amplify a 397-bp region from the eaeA gene
(primers AE20-2 and AE22) and a 166-bp fragment from the
ehxA gene (primers MFS-1F and MFS-1R) (16).
Each 100 µl of the PCR mixture contained each deoxynucleotide
triphosphate at a concentration of 200 µM, each primer at a
concentration of 300 nM, 1× PCR buffer (50 mM KCl, 2.5 mM
MgCl2, 10 mM Tris-HCl [pH 8.3]), and 0.5 µl (2.5 U) of
AmpliTaq Gold polymerase (PE Applied Biosystems, Foster City, Calif.).
The template DNA was prepared by suspending a single colony in 100 µl
of TE (Tris-EDTA) buffer; the suspension was then heated for 5 min in a
boiling water bath, chilled on ice for 5 min, and centrifuged to remove
debris. Prior to amplification, the reagents were mixed and heated at
95°C for 7 min to activate AmpliTaq Gold, and then 5 µl of template
was added and the mixture was heated for an additional 5 min. Samples
were amplified for 25 cycles of 1 min at 94°C, 1 min at 56°C, and 1 min at 72°C, followed by a final extension of 7 min at 72°C. The
PCR products were examined by agarose gel (1%) electrophoresis in TBE
(Tris-borate-EDTA) buffer (pH 8.2).
Analysis for intimin derivatives.
Pathogenic E. coli produces at least five distinct intimin derivatives
(1), which are designated 
, 
, 
, 
, and NT
(nontypeable). The eaeA primers used in our multiplex PCR
are specific for the 3' end of the eaeA gene of serotype
O157:H7, which produces -intimin (22). However, other
EHEC serotypes are reported to carry other intimin derivatives; hence,
O104:H21 strains were also tested separately by PCR for the presence of
genes for these derivatives. The primer sequences and procedure for
amplifying -eaeA and -eaeA have been
described by Reid et al. (22). Strains E2348/69 (EPEC O127:H6) and 13C60 (EHEC O26:H11) were used as positive controls for
- and -eaeA, respectively.
Analysis for enterohemolysin.
Phenotypic assay for
enterohemolysin activity was done on washed sheep blood agar plates
containing calcium (3). The medium was prepared by
supplementing tryptic soy agar with 10 mM CaCl2 (pH 7.3)
and 5% defibrinated sheep blood that was washed three times in
phosphate-buffered saline. Isolates were also tested for the presence
of the ehxA gene with another set of PCR primers (hlyA1 and
hlyA4) as described by Schmidt et al. (25).
To examine the genetic sequence of the MFS-1F and MFS-1R primer binding
region, the ehxA gene of O157:H7 and O104:H21 was amplified,
cloned, and sequenced as follows. A small amount of bacterial colony
was directly added to 44 µl of an amplification mixture containing
1× Thermopol buffer (New England Biolabs, Beverly, Mass.), 2 mM
MgSO4, each deoxynucleoside triphosphate at a concentration of 200 µM, and the 5' primer hlyAalt1 (5'-CCA GGA GAA GAA GTT AGA G-3') and the 3' primer MFS-1R each at a concentration of 200 nM. This primer pair amplifies a 368-bp fragment (nucleotides [nt]
1612 to 1980) of the ehxA gene that includes the MFS-1F
binding site. The PCR mixtures were heated at 95°C for 5 min, at
which time 0.5 U of Vent DNA polymerase (New England Biolabs) in 5 µl of 1× Thermopol buffer was added to yield a final reaction volume of
50 µl. After heating for another 5 min at 95°C, the samples were
amplified for 32 cycles, with each cycle consisting of 95°C for 1 min, 51°C for 45 s, and 75°C for 1 min, followed by a final 10-min extension at 75°C. The PCR products were examined on a 1%
agarose gel in 0.5× TBE buffer. By using the described procedure (23), the desired fragments were excised, recovered from
the gel, ligated into EcoRV-digested pBluescript SK(
), and
electroporated into E. coli DH5. Recombinants were
examined for plasmids containing fragments of the expected size by
screening by PCR with the vector-specific T3 and T7 promoter primers.
Plasmids prepared from these clones were sequenced by Amplicon Express
(Pullman, Wash.) by using the Automated Applied Biosystems Sequencing system.
| |
RESULTS |
PCR analysis for virulence genes.
Multiplex PCR amplification
showed that the O157:H7-positive control strain carried all four trait
EHEC virulence markers as well as the +93 uidA mutation that
is characteristic for this serotype (9) (Fig.
1, lane 2). The O104:H21 strains examined did not have the uidA mutation, eaeA, or
ehxA and carried only the stx2 gene (Fig. 1,
lanes 5, 6, and 7). Serological testing with Verotox-F (Denka Seiken,
Tokyo, Japan), a reverse passive latex agglutination test, confirmed
that Stx2 was produced by O104:H21. The absence of both
eaeA and ehxA genes in O104:H21 seemed unusual.
Many non-O157:H7 EHEC serotypes that have been implicated in illness
usually carried combinations of the stx genes and the
eaeA or ehxA gene, or both (2, 8,
20); hence, the apparent absence of the last two virulence
markers in O104:H21 strains was investigated further.
View larger version (121K):
[in this window]
[in a new window]
|
FIG. 1.
Agarose gel electrophoresis of DNA fragments amplified
by multiplex PCR specific for EHEC virulence genes and other trait
markers of O157:H7 serotype. Lane 1, 100-bp DNA ladder (Life
Technologies, Rockville, Md.); lane 2, 35150 (EHEC O157:H7), positive
control; lane 3, E2348/69 (EPEC O127:H6), negative control; lane 4, 13C60 (EHEC O26:H11); lanes 5 (G5507), 6 (G5506), and 7 (G5508),
strains of the O104:H21 serotype. The amplified products (sizes are in
base pairs) from the O157:H7-positive control shown in lane 2 are, from
top to bottom, stx2 (584 bp), eaeA (397 bp),
stx1 (348 bp), uidA (252 bp), and ehxA
(166 bp).
|
|
Analysis for intimin derivatives.
Multiplex PCR assay showed
that O104:H21 strains did not carry the eaeA gene for the
-intimin derivative that is typical of the O157:H7 serotype. PCR
analysis with primers specific for - and -intimin derivatives
showed that amplicons of the expected sizes for these primers for
-intimin (1,648 bp) and -intimin (1,926 bp) were obtained from
the respective control strains. However, none of the O104:H21 strains
carried the eaeA genes for either the -intimin or the
-intimin derivative (data not shown).
Analysis for enterohemolysin.
Multiplex PCR also showed that
O104:H21 strains did not carry the ehxA gene that encodes
enterohemolysin. However, phenotypic assays showed that these
strains exhibited enterohemolysin activity on enhanced blood agar
plates (data not shown). To resolve this discrepancy, we tested
O104:H21 isolates using another set of primers, hlyA1 and hlyA4
(25), which amplify a 1,551-bp fragment (nt 238 to 1789)
that is 25 bp upstream from the 166-bp fragment (nt 1814 to 1900)
amplified by MFS-1F and MFS-1R primers used in the multiplex PCR.
Agarose gel electrophoresis showed that all isolates of O104:H21 had
the expected 1,551-bp fragment from the ehxA gene (Fig.
2, lanes 4, 5, and 6), confirming the
phenotypic data that indicated that these strains are hemolytic.
View larger version (80K):
[in this window]
[in a new window]
|
FIG. 2.
Agarose gel electrophoresis of DNA fragments amplified
from the ehxA gene by PCR with primers hlyA1 and hlyA4. Lane
1, 100-bp DNA ladder (Life Technologies); lane 2, 35150 (O157:H7);
positive control; lane 3, DH5, negative control; lanes 4 to 6, O104:H21 strains G5508, G5507, and G5506, respectively. The top two
bands of the size ladder are 2,072 and 1,500 bp, respectively.
|
|
Since O104:H21 strains carry the ehxA gene, the absence of
the ehxA-specific product from these strains in PCRs with
our multiplex primers (primers MFS-1F and MFS-1R) was puzzling,
especially since good amplification of ehxA was obtained
from O157:H7 with these primers (Fig. 1, lane 2), as well as with
primers hlyA1 and hlyA4 (Fig. 2, lane 2). The presence of base
mutations in either the MFS-1F or MFS-1R binding sites may cause the
absence of the ehxA-specific PCR product from O104:H21. To
determine if MFS-1R was functional, a PCR combining upstream primer
hlyA1 and downstream primer MFS-1R was used to test O104:H21 isolates.
The expected size of the product would be 1,742 bp, consisting of the
1,551 bp from hlyA1 to hlyA4, the 166 bp from MFS-1F to MFS-1R, and the
25 bp between the two fragments. PCR analysis showed that amplicons
approximating the expected size of 1,742 bp were obtained from the
O157:H7-positive control, as well as from the O104:H21 strains examined
(data not shown). This finding showed that the downstream MFS-1R
binding region in O104:H21 is functional and that genetic variation
most likely resides in the MFS-1F binding site. Sequence analysis of a
368-bp fragment that contained this region showed that the
ehxA sequence of O157:H7 was identical to the published
sequence (25). However, the ehxA gene of
O104:H21 contained 9 base mutations, of which 3 were in the MFS-1F
region, including an A-to-G substitution at the 3' end of the primer
binding site (Fig. 3).
View larger version (11K):
[in this window]
[in a new window]
|
FIG. 3.
Partial nucleotide sequence of ehxA gene
showing the MFS-1F primer binding site. Sequences shown are
hlyA (O157:H7), published by Schmidt et al.
(25); O157:H7 (strain 35150); and O104:H21 (strain G5507).
The mismatched bases are shaded. The region indicated by MFS-1Fb shows
the new primer sequence, which, with MFS-1R, amplifies the
ehxA genes from strains of both serotypes O157:H7 and
O104:H21.
|
|
| |
DISCUSSION |
Evolutionary analyses have subdivided the EHEC and
EPEC pathogenic groups into four distinct clones. EHEC 1 is composed
mostly of the O157:H7 serotype, but includes the O55:H7 serotype; EHEC 2 includes Stx-producing O26 and O111 serotypes; EPEC 1 is represented by strain E2348/69, an O127:H6 serotype strain; and EPEC 2 includes Stx-nonproducing O26 and O111 serotype strains (26, 27). A genetic relatedness analysis of an O104:H21 isolate (isolate
G5506) from the Montana outbreak showed that this strain was not an
EHEC 1 or EHEC 2 clone; rather, it is closer in genetic distance to EHEC 2 (26). Consistent with those findings, our results
showed that O104:H21 strains did not have the +93 uidA
mutation, which is found only in O157:H7 serotype strains of the EHEC 1 clone. The production of Stx varies among the various EHEC serotypes and clonal groups, as some produce Stx1, or Stx2, or both. The O104:H21
strains examined here produced only Stx2.
Among EHEC virulence factors, intimin and Stx2 seem to be strongly
associated with severe illness in humans (8). The
eaeA gene, which encodes intimin, is found in both EHEC and
EPEC strains. There are at least five distinct intimin derivatives
(1), and of these, -, -, and -intimins are
characteristic of the EPEC 1, EPEC 2, and EHEC 1 groups, respectively
(22). The eaeA-specific primers used in our
multiplex PCR are designed to detect the 3' end of the eaeA
gene of O157:H7 and, therefore, are specific only for -intimin
(15). These primers have been shown to react only with
isolates of the O157:H7 and EPEC O55:H7 serotypes (15), which are very closely related genetically and which are in the same
clonal group (14). The O104:H21 isolates did not react with these eaeA-specific primers and therefore did not carry
the gene encoding the -intimin derivative. Strains in the EHEC 2 clonal group are related genetically to strains in the EPEC 2 clonal
group, as both groups include strains of the O26 and O111 serotypes and
produce -intimin (26). Since O104:H21 is closer in
genetic distance to EHEC 2 (26), it was possible that it also produced -intimin. However, PCR analysis showed that O104:H21 strains carried neither the -intimin nor the -intimin gene. We
did not look for -intimin or NT intimin, but these derivatives are
rare and are found in only a few serotypes (1); therefore, they are unlikely to be present in the O104:H21 isolates. Although O104:H21 strains do not appear to carry intimin, it does not rule out
the presence of other adherence factors. An O113:H21 strain, isolated
from a HUS patient, also produced Stx2 and did not carry eaeA, but it exhibited an adhesion pattern that was distinct
from the typical attachment-and-effacing lesion of intimin
(11).
The enterohemolytic phenotype is present in most O157:H7 isolates and
is regarded as a trait characteristic of this serotype; however, it is
also closely associated with other Stx-producing E. coli
strains, as most O111 isolates from HUS patients were enterohemolytic
(24). The enterohemolysin or EHEC hemolysin is encoded by
the ehxA gene, which resides on a large plasmid (25), and the toxin is related to but is not identical to
the -hemolysin of E. coli in that they share about 60%
sequence homology (24). Since enterohemolysin production
seems to be closely associated with Stx production (5,
18), it was suggested that it may be a reliable epidemiological
marker when testing for Stx-producing E. coli in clinical
samples (4). The MFS-1F and MFS-1R primers used in our
multiplex PCR are designed to be specific for the ehxA gene
of O157:H7; but they also detected ehxA genes in strains of
serotypes O26:H11, O111:NM (NM indicates nonmotile), O165:H25, O145:NM,
O103:H2, O22:H8, O121:H19, O125:NM, and O45:H2 and strains of other
serotypes (15; unpublished data). Although the
ehxA genes of most serotypes have not been sequenced, that
of O111 strains has been determined and found to be 99.4% identical to that of O157:H7 strains (24); therefore, it supports the
observations that primers MFS-1F and MFS-1R will recognize
ehxA genes of other serotypes. Results of our analyses,
however, showed that these same primers are not effective in detecting
the ehxA gene of O104:H21 strains from the Montana outbreak.
A partial sequence analysis showed that the ehxA gene of
O104:H21 was not identical to that of O157:H7, as it contained several
base mutations, some of which are in the MFS-1F binding site. These
mutations do not appear to be unique to O104:H21, as the
ehxA genes of enterohemolytic O48:H21 (strain 13C09) and
ON:HN (nontypeable) strains were also not amplified by MFS-1F and
MFS-1R but were amplified by hlyA1 and hlyA4 (data not shown). Boerlin
et al. (7) showed that the ehxA genes of
Stx-producing E. coli strains cluster in two groups. The
ehxA genes of strains in cluster I, which include strains of
serotypes O157:H7, O26, and O111 and strains of other serotypes, share
98 and 97.3% homologies at the DNA and amino acid levels,
respectively, with strains in cluster II, such as strains of serotypes
O113:H21 and O8:H19 and strains of other serotypes. Specifically, the
regions between amino acids 312 and 660 and amino acids 835 and 948 showed the highest degree of variation, with rates of substitution
ranging from 5.7 to 7% (7). The ehxA gene
region of the O104:H21 strains that we examined lies between amino
acids 538 and 661; hence, the genetic variation that we noted is
consistent with the findings of Boerlin et al. (7).
Moreover, the sequence of the 368-bp fragment cloned from the
ehxA gene of O104:H21 closely resembled that of the fragment cloned from the ehxA gene of O8:H19, which consists of
cluster II strains (7), suggesting that O104:H21 also
belongs in the cluster II group.
Primers MFS-1F and MFS-1R have been used to test for ehxA
genes in E. coli isolates (15) and in other
multiplex PCRs to characterize the virulence factors of Stx-producing
E. coli strains isolated from animal feces
(12). However, since these primers did not amplify the
ehxA genes of some EHEC strains, presumably due to the
A-to-G substitution at the 3' end of the MFS-1F binding site, we
modified this primer by shifting it 8 bases downstream and renaming it
MFS-1Fb (Fig. 3). We compared the MFS-1Fb and MFS-1R sequences with
that of hlyA, which encodes -hemolysin (13),
and also tested them by PCR with -hemolytic E. coli
strains to ensure that these primers did not bind to hlyA.
Substituting MFS-1Fb for MFS-1F in the multiplex PCR cocktail and using
identical PCR conditions, we found that we were able to effectively
amplify the ehxA genes of EHEC strains from cluster I
(O157:H7), cluster II (O113:H21) (not shown), and O104:H21 (Fig.
4).
View larger version (60K):
[in this window]
[in a new window]
|
FIG. 4.
Agarose gel electrophoresis of DNA fragments amplified
by multiplex PCR with primer MFS-1Fb instead of primer MFS-1F for
amplification of ehxA. Lane 1, 123-bp DNA ladder (Sigma, St.
Louis, Mo.); lane 2, 35150 (O157:H7), positive control; lane 3, G5507
(O104:H21). The amplified products (sizes are in base pairs) from
O157:H7 shown in lane 2 are, from top to bottom, stx2 (584 bp), eaeA (397 bp), stx1 (348 bp),
uidA (252 bp), and ehxA (158 bp).
|
|
Results from these studies show that the O104:H21 strain, implicated in
the HC outbreak in Montana, does not have eaeA but produces
Stx2 and enterohemolysin. Other EHEC serotypes with similar combinations of virulence factors have also been implicated in HUS
(21). Genetic analysis showed that the ehxA
genes of O104:H21 strains contained base mutations that are not found
in O157:H7 strains and that the ehxA sequences of O104:H21
strains resembled those of cluster II Stx-producing strains rather than
those of cluster I Stx-producing strains (O157:H7). By modifying one of the ehxA primers, the multiplex PCR assay is able to detect
ehxA genes from both hemolysin gene clusters, including
O104:H21, and may be useful in the analysis of virulence factors in
other EHEC isolates.
We thank N. Strockbine and S. Abbott for providing cultures and
T. Whittam for helpful discussions and for critical reading of the manuscript.
| 1.
|
Adu-Robie, J.,
G. Frankel,
C. Bain,
A. G. Goncalves,
L. R. Trabulsi,
G. Douce,
S. Knutton, and G. F. Dougan.
1998.
Detection of intimins , , , and , four intimin derivatives expressed by attachment and effacing microbial pathogens.
J. Clin. Microbiol.
36:662-668[Abstract/Free Full Text].
|
| 2.
|
Barrettt, T. J.,
J. B. Kaper,
A. E. Jerse, and I. K. Wachsmuth.
1992.
Virulence factors in Shiga-like toxin-producing Escherichia coli isolated from humans and cattle.
J. Infect. Dis.
165:979-980[Medline].
|
| 3.
|
Bettelheim, K. A.
1995.
Identification of enterohaemorrhagic Escherichia coli by means of their production of enterohaemolysin.
J. Appl. Bacteriol.
79:178-180[Medline].
|
| 4.
|
Beutin, L.,
S. Aleksic,
S. Zimmermann, and K. Gleier.
1994.
Virulence factors and phenotypic traits of verotoxigenic strains of Escherichia coli isolated from human patients in Germany.
Med. Microbiol. Immunol.
183:13-21[Medline].
|
| 5.
|
Beutin, L.,
M. Montenegro,
I. Orskov,
F. Orskov,
J. Prada,
S. Zimmermann, and R. Stephan.
1989.
Close association of verotoxin (Shiga-like toxin) production with enterohemolysin production in strains of Escherichia coli.
J. Clin. Microbiol.
27:2559-2564[Abstract/Free Full Text].
|
| 6.
|
Bockemuhl, J.,
S. Aleksic, and H. Karch.
1992.
Serological and biochemical properties of Shiga-like toxin (verocytotoxin)-producing strains of Escherichia coli, other than O-group 157, from patients in Germany.
Zentbl. Bakteriol. Parasitenkd. Infektcankh. Nyg. Abt. 1 Orig.
276:189-195.
|
| 7.
|
Boerlin, P.,
S. Chen,
J. K. Colbourne,
R. Johnson,
S. DeGrandis, and C. Gyles.
1998.
Evolution of enterohemorrhagic Escherichia coli hemolysin plasmid and the locus for enterocyte effacement in Shiga toxin-producing E. coli.
Infect. Immun.
66:2553-2561[Abstract/Free Full Text].
|
| 8.
|
Boerlin, P.,
S. A. McEwen,
F. Boerlin-Petzold,
J. B. Wilson,
R. Johnson, and C. Gyles.
1999.
Association between virulence factors of Shiga toxin-producing Escherichia coli and disease in human.
J. Clin. Microbiol.
37:497-503[Abstract/Free Full Text].
|
| 9.
|
Cebula, T. A.,
W. L. Payne, and P. Feng.
1995.
Simultaneous identification of strains of Escherichia coli serotype O157:H7 and their Shiga-like toxin type by mismatch amplification mutation assay-multiplex PCR.
J. Clin. Microbiol.
33:248-250[Abstract].
|
| 10.
|
Centers for Disease Control and Prevention.
1995.
Outbreak of acute gastroenteritis attributed to Escherichia coli serotype O104:H21 Helena, Montana, 1994.
JAMA
274:529-530[CrossRef][Medline].
|
| 11.
|
Dytoc, M. T.,
A. Ismaili,
D. J. Philpott,
R. Soni,
J. L. Brunton, and P. M. Sherman.
1994.
Distinct binding properties of eaeA-negative verocytotoxin-producing Escherichia coli of serotype O113:H21.
Infect. Immun.
62:3494-3505[Abstract/Free Full Text].
|
| 12.
|
Fagan, P. K.,
M. A. Hornitzky,
K. A. Bettelheim, and S. P. Djordjevic.
1999.
Detection of Shiga-like toxin (stx1 and stx2), intimin (eaeA), and enterohemorrhagic Escherichia coli (EHEC) hemolysin (EHEC hlyA) genes in animal feces by multiplex PCR.
Appl. Environ. Microbiol.
65:868-872[Abstract/Free Full Text].
|
| 13.
|
Felmlee, T.,
S. Pellett, and R. A. Welch.
1985.
Nucleotide sequence of an Escherichia coli chromosomal hemolysin.
J. Bacteriol.
163:94-105[Abstract/Free Full Text].
|
| 14.
|
Feng, P.,
K. A. Lampel,
H. Karch, and T. S. Whittam.
1998.
Sequential genotypic and phenotypic changes in the emergence of Escherichia coli O157:H7.
J. Infect. Dis.
177:1750-1753[CrossRef][Medline].
|
| 15.
|
Fratamico, P. M.,
S. K. Sackitey,
M. Wiedmann, and M. Y. Deng.
1995.
Detection of Escherichia coli O157:H7 by multiplex PCR.
J. Clin. Microbiol.
33:2188-2191[Abstract].
|
| 16.
|
Fratamico, P. M., and T. P. Strobaugh.
1998.
Simultaneous detection of Salmonella spp and Escherichia coli O157:H7 by multiplex PCR.
J. Ind. Microbiol. Biotechnol.
21:92-98[CrossRef].
|
| 17.
|
Goldwater, P. N., and K. A. Bettelheim.
1998.
New perspectives on the role of Escherichia coli O157:H7 and other enterohemorrhagic E. coli serotypes in human disease.
J. Med. Microbiol.
47:1039-1045[Abstract].
|
| 18.
|
Gyles, C.,
R. Johnson,
A. Gao,
K. Ziebell,
D. Pierard,
S. Aleksic, and P. Boerlin.
1998.
Association of enterohemorrhagic Escherichia coli hemolysin with serotypes of Shiga-like-toxin-producing Escherichia coli of human and bovine origin.
Appl. Environ. Microbiol.
64:4131-4141.
|
| 19.
|
Johnson, R. P.,
R. C. Clarke,
J. B. Wilson,
S. C. Read,
K. Rahn,
S. A. Renwick,
K. A. Sandhu,
D. Alves,
M. A. Karmali,
H. Lior,
S. A. Mcewen,
J. S. Spika, and C. L. Gyles.
1996.
Growing concerns and recent outbreak involving non-O157:H7 serotypes of verotoxigenic Escherichia coli.
J. Food Prot.
59:1112-1122.
|
| 20.
|
Levine, M. M.,
J. G. Xu,
J. B. Kaper,
H. Lior,
V. Prado,
B. Tall,
J. Nataro,
H. Karch, and I. K. Wachsmuth.
1987.
A DNA probe to identify enterohemorrhagic Escherichia coli of O157:H7 serotype and other serotypes that cause hemorrhagic colitis and hemolytic uremic syndrome.
J. Infect. Dis.
156:175-182[Medline].
|
| 21.
|
Paton, A. W.,
M. C. Woodrow,
R. M. Doyle,
J. A. Lanser, and J. C. Paton.
1999.
Molecular characterization of a Shiga toxigenic Escherichia coli O113:H21 strain lacking eae responsible for a cluster of cases of hemolytic-uremic syndrome.
J. Clin. Microbiol.
37:3357-3361[Abstract/Free Full Text].
|
| 22.
|
Reid, S. D.,
D. J. Betting, and T. S. Whittam.
1999.
Molecular identification of intimin alleles in pathogenic Escherichia coli by multiplex PCR.
J. Clin. Microbiol.
37:2719-2722[Abstract/Free Full Text].
|
| 23.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 24.
|
Schmidt, H., and H. Karch.
1996.
Enterohemolytic phenotypes and genotypes of Shiga toxin-producing Escherichia coli O111 strains from patients with diarrhea and hemolytic-uremic syndrome.
J. Clin. Microbiol.
34:2364-2367[Abstract].
|
| 25.
|
Schmidt, H.,
L. Beutin, and H. Karch.
1995.
Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933.
Infect. Immun.
63:1055-1061[Abstract].
|
| 26.
|
Whittam, T. S.
1998.
Evolution of Escherichia coli O157:H7 and other Shiga-toxin producing E. coli strains, p. 195-209.
In
J. B. Kaper, and A. D. O'Brien (ed.), Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. American Society for Microbiology, Washington, D.C.
|
| 27.
|
Whittam, T. S., and E. A. McGraw.
1996.
Clonal analysis of EPEC serogroups.
Rev. Microbiol. Sao Paulo
27:7-16.
|
| 28.
|
Willshaw, G. A.,
S. M. Scotland,
H. R. Smith, and B. Rowe.
1992.
Properties of Verocytotoxin-producing Escherichia coli of human origin of O sergroups other than O157.
J. Infect. Dis.
166:797-802[Medline].
|
![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
Top
Abstract
Introduction
